13592 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 272 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
PRF1Perforin 1Cancer-related genes
Disease related genes
Potential drug targets
Predicted secreted proteins
Transporters
CytosolRenal cancer: 1.08e-5
Endometrial cancer: 2.09e-4
Head and neck cancer: 3.54e-4
Tissue enhanced
PRG2Proteoglycan 2, pro eosinophil major basic proteinPlasma proteins
Predicted secreted proteins
Tissue enriched
PRH1Proline rich protein HaeIII subfamily 1Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
PRH2Proline rich protein HaeIII subfamily 2Predicted secreted proteins
Tissue enriched
PRICKLE1Prickle planar cell polarity protein 1Disease related genes
Predicted intracellular proteins
NucleoplasmGlioma: 5.56e-4
Mixed
PRICKLE2Prickle planar cell polarity protein 2Disease related genes
Plasma proteins
Predicted intracellular proteins
Golgi apparatus
Vesicles
Mixed
PRICKLE3Prickle planar cell polarity protein 3Predicted intracellular proteins
Nucleus
Plasma membrane
Centrosome
Renal cancer: 5.73e-6
Urothelial cancer: 4.84e-5
Mixed
PRIM1Primase (DNA) subunit 1Predicted intracellular proteins
VesiclesLiver cancer: 2.40e-8
Expressed in all
PRIM2Primase (DNA) subunit 2Plasma proteins
Predicted intracellular proteins
NucleoplasmRenal cancer: 7.34e-6
Ovarian cancer: 3.00e-5
Liver cancer: 3.44e-5
Pancreatic cancer: 5.25e-4
Endometrial cancer: 6.98e-4
Tissue enhanced
PRIMA1Proline rich membrane anchor 1Predicted membrane proteins
Nucleoli
Plasma membrane
Cytosol
Renal cancer: 2.62e-7
Endometrial cancer: 6.99e-5
Mixed
PRIMPOLPrimase and DNA directed polymeraseDisease related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Mixed
PRKAA1Protein kinase AMP-activated catalytic subunit alpha 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nuclear specklesExpressed in all
PRKAB1Protein kinase AMP-activated non-catalytic subunit beta 1FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 5.40e-9
Endometrial cancer: 8.66e-4
Expressed in all
PRKAB2Protein kinase AMP-activated non-catalytic subunit beta 2Predicted intracellular proteins
NucleoplasmThyroid cancer: 6.78e-7
Breast cancer: 4.55e-4
Head and neck cancer: 7.32e-4
Expressed in all
PRKACAProtein kinase cAMP-activated catalytic subunit alphaCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
CytosolCervical cancer: 6.28e-6
Endometrial cancer: 6.26e-5
Pancreatic cancer: 6.47e-4
Expressed in all
PRKACBProtein kinase cAMP-activated catalytic subunit betaEnzymes
Predicted intracellular proteins
RAS pathway related proteins
CytosolRenal cancer: 1.89e-6
Liver cancer: 9.49e-4
Tissue enriched
PRKAG1Protein kinase AMP-activated non-catalytic subunit gamma 1Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Nuclear bodies
Cytosol
Liver cancer: 2.84e-7
Renal cancer: 1.83e-4
Expressed in all
PRKAG2Protein kinase AMP-activated non-catalytic subunit gamma 2Disease related genes
Plasma proteins
Predicted intracellular proteins
NucleoplasmExpressed in all
PRKAR1AProtein kinase cAMP-dependent type I regulatory subunit alphaCancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
CytosolExpressed in all
PRKAR1BProtein kinase cAMP-dependent type I regulatory subunit betaPredicted intracellular proteins
Tissue enriched
PRKAR2AProtein kinase cAMP-dependent type II regulatory subunit alphaPlasma proteins
Predicted intracellular proteins
Golgi apparatus
Vesicles
Microtubule organizing center
Colorectal cancer: 4.27e-5
Liver cancer: 1.97e-4
Renal cancer: 2.07e-4
Expressed in all
PRKAR2BProtein kinase cAMP-dependent type II regulatory subunit betaPredicted intracellular proteins
Golgi apparatus
Centrosome
Mitochondria
Cytosol
Pancreatic cancer: 4.03e-4
Colorectal cancer: 6.38e-4
Thyroid cancer: 8.74e-4
Tissue enhanced
PRKCAProtein kinase C alphaCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Plasma membrane
Cytosol
Mixed
PRKCBProtein kinase C betaCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Nucleoplasm
Cytosol
Tissue enhanced
PRKCDProtein kinase C deltaCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Endoplasmic reticulum
Golgi apparatus
Cytosol
Liver cancer: 2.24e-4
Lung cancer: 9.01e-4
Mixed
PRKCDBPProtein kinase C delta binding proteinPredicted intracellular proteins
Plasma membraneRenal cancer: 5.21e-6
Cervical cancer: 3.75e-5
Mixed
PRKCEProtein kinase C epsilonCancer-related genes
Enzymes
Predicted intracellular proteins
VesiclesRenal cancer: 2.63e-7
Endometrial cancer: 2.42e-4
Lung cancer: 9.62e-4
Tissue enhanced
PRKCHProtein kinase C etaCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Plasma membrane
Cytosol
Head and neck cancer: 8.55e-6
Expressed in all
PRKCIProtein kinase C iotaCancer-related genes
Enzymes
Predicted intracellular proteins
Microtubules
Cytokinetic bridge
Cytosol
Endometrial cancer: 3.93e-6
Pancreatic cancer: 1.22e-4
Liver cancer: 3.02e-4
Renal cancer: 3.10e-4
Expressed in all
PRKCSHProtein kinase C substrate 80K-HDisease related genes
Plasma proteins
Predicted secreted proteins
Endoplasmic reticulumRenal cancer: 7.69e-4
Expressed in all
PRKCZProtein kinase C zetaEnzymes
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Renal cancer: 1.64e-9
Tissue enhanced
PRKD1Protein kinase D1Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Renal cancer: 2.44e-5
Thyroid cancer: 2.91e-4
Tissue enhanced
PRKD2Protein kinase D2Enzymes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Urothelial cancer: 9.15e-4
Expressed in all
PRKD3Protein kinase D3Enzymes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Liver cancer: 3.47e-4
Colorectal cancer: 4.84e-4
Expressed in all
PRKDCProtein kinase, DNA-activated, catalytic polypeptideCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
NucleoplasmEndometrial cancer: 1.03e-4
Expressed in all
PRKG1Protein kinase, cGMP-dependent, type IDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Vesicles
Cytosol
Mixed
PRKRAProtein activator of interferon induced protein kinase EIF2AK2Disease related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Liver cancer: 8.33e-5
Testis cancer: 5.45e-4
Expressed in all
PRKRIP1PRKR interacting protein 1 (IL11 inducible)Predicted intracellular proteins
Actin filaments
Cytosol
Urothelial cancer: 1.94e-4
Colorectal cancer: 3.65e-4
Renal cancer: 4.39e-4
Expressed in all
PRKXProtein kinase, X-linkedDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
NucleusTissue enhanced
PRLProlactinCancer-related genes
Plasma proteins
Predicted secreted proteins
CytosolGroup enriched
PRLRProlactin receptorDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PRMT1Protein arginine methyltransferase 1Enzymes
Plasma proteins
Predicted intracellular proteins
NucleoplasmLiver cancer: 8.04e-5
Expressed in all
PRMT2Protein arginine methyltransferase 2Enzymes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
PRMT3Protein arginine methyltransferase 3Predicted intracellular proteins
Liver cancer: 2.81e-5
Pancreatic cancer: 3.17e-5
Expressed in all
PRMT5Protein arginine methyltransferase 5Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol
Liver cancer: 4.77e-5
Urothelial cancer: 1.04e-4
Head and neck cancer: 1.82e-4
Pancreatic cancer: 2.61e-4
Expressed in all
PRMT6Protein arginine methyltransferase 6Enzymes
Predicted intracellular proteins
Nucleus
Nucleoli
Endometrial cancer: 3.05e-4
Mixed
PRMT7Protein arginine methyltransferase 7Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleoplasm
Nucleoli fibrillar center
Endometrial cancer: 2.31e-5
Expressed in all
PRMT9Protein arginine methyltransferase 9Predicted intracellular proteins
Nucleoplasm
Microtubules
Cytosol
Renal cancer: 3.58e-7
Mixed
PRNPPrion proteinCD markers
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Nuclear membrane
Vesicles
Cytosol
Liver cancer: 7.41e-5
Glioma: 1.99e-4
Colorectal cancer: 2.96e-4
Endometrial cancer: 4.64e-4
Expressed in all
PROCA1Protein interacting with cyclin A1Predicted intracellular proteins
Tissue enriched
« prev | Page of 272 | next »